Short Bowel Syndrome Market Growth | Trends, Treatment Advances & Forecast 2025 | Top key players - OxThera Inc, VectivBio AG, Nutrinia.

Short Bowel Syndrome Market, as analyzed in the study by DataM Intelligence, presents a detailed overview of the industry with in-depth insights, historical data, and key statistics. The report thoroughly examines market dynamics, competitive strategies, and major players, highlighting their product lines, pricing structures, financials, growth plans, and regional outreach.

The Short Bowel Syndrome Market is estimated to reach at a CAGR of 15.9% during the forecast period (2024-2031).

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID) @ https://datamintelligence.com/download-sample/short-bowel-syndrome-market?sz

The Short Bowel Syndrome Market focuses on treatments and therapies for patients with significant loss of small intestine, leading to poor nutrient absorption. It includes specialized nutritional support, medications, and surgical options aimed at improving digestion and quality of life. Growing awareness and advanced therapies are driving market growth worldwide.

Major players in the Short Bowel Syndrome Market

The prominent players in Short Bowel Syndrome market research report are: Takeda Pharmaceutical Company Limited, OxThera Inc, VectivBio AG, Nutrinia, Merck KGaA, Pfizer Inc, Ardelyx, Zealand Pharma, and Nestlé S.A.

The companies are primarily focusing on strategies such as new product launches to penetrate the fastest-growing emerging markets across the world.

Key Development

In December 2020, 9 Meters Biopharma, Inc. shared encouraging topline results from its Phase 1b/2a open-label clinical trial of NM-002, a long-acting injectable treatment developed for adults with short bowel syndrome (SBS). NM-002, which leverages the company's proprietary XTEN® technology, is a GLP-1 receptor agonist designed to slow down digestive transit and reduce upper GI motility. The goal: help manage chronic diarrhea and improve quality of life for patients living with SBS.

Speak to Our Senior Analyst and Get Customization in the report as per your requirements @ https://datamintelligence.com/customize/short-bowel-syndrome-market

Market Segments

By Drug Class: GLP-2, Growth Hormone, Glutamine, Others.

By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Others.

The Short Bowel Syndrome industry is experiencing rapid growth, driven by advancements in medical technologies, increased demand for innovative therapies, and a rising focus on patient-centered care. As these sectors evolve, the need for comprehensive market analysis becomes crucial to understand trends, regulatory changes, and emerging opportunities.

Regions Covered:

The global Short Bowel Syndrome Market report focuses on six major regions: North America, South America, Europe, Asia Pacific, the Middle East, and Africa.

☞ North America - US, Canada, Mexico

☞ Europe- Germany, Russia, UK, France, Italy, Rest of Europe

☞ Asia Pacific- China, India, Japan, Australia, Rest of Asia Pacific

☞ South America- Brazil, Argentina, Colombia, Rest of South America

☞ Middle East and Africa- Saudi Arabia, UAE, Oman, Bahrain, Qatar, Kuwait, Israel

Benefits of the Report:

➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.

➡ Top-down and bottom-up approach for regional analysis

➡ Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.

➡ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market

Stay informed with the latest industry insights-start your subscription now: https://www.datamintelligence.com/reports-subscription

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.